PERI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 32.868
EU - Europa 16.228
AS - Asia 8.385
SA - Sud America 1.236
AF - Africa 147
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 17
Totale 58.900
Nazione #
US - Stati Uniti d'America 32.390
DE - Germania 5.575
DK - Danimarca 2.806
SG - Singapore 2.778
IT - Italia 2.483
CN - Cina 2.244
RU - Federazione Russa 1.183
VN - Vietnam 1.163
HK - Hong Kong 1.139
BR - Brasile 1.030
SE - Svezia 873
IE - Irlanda 627
UA - Ucraina 517
GB - Regno Unito 483
PL - Polonia 394
CA - Canada 372
FR - Francia 350
AT - Austria 231
IN - India 223
FI - Finlandia 205
NL - Olanda 165
KR - Corea 157
ID - Indonesia 133
TR - Turchia 100
JP - Giappone 99
BE - Belgio 94
BD - Bangladesh 83
ES - Italia 79
AR - Argentina 70
MX - Messico 70
ZA - Sudafrica 60
IQ - Iraq 49
EC - Ecuador 39
RO - Romania 30
PK - Pakistan 29
IR - Iran 27
CH - Svizzera 25
LT - Lituania 25
CO - Colombia 22
UZ - Uzbekistan 21
CL - Cile 18
IL - Israele 18
MA - Marocco 18
PY - Paraguay 17
TW - Taiwan 17
VE - Venezuela 17
CZ - Repubblica Ceca 15
EG - Egitto 15
KE - Kenya 15
AE - Emirati Arabi Uniti 14
AU - Australia 12
EU - Europa 12
GR - Grecia 12
SA - Arabia Saudita 12
AZ - Azerbaigian 11
DZ - Algeria 11
MY - Malesia 11
NP - Nepal 11
PT - Portogallo 10
PH - Filippine 9
ET - Etiopia 8
PE - Perù 8
TN - Tunisia 8
UY - Uruguay 8
BG - Bulgaria 7
JM - Giamaica 6
JO - Giordania 6
NO - Norvegia 6
TT - Trinidad e Tobago 6
AL - Albania 5
BB - Barbados 5
DO - Repubblica Dominicana 5
HU - Ungheria 5
KZ - Kazakistan 5
MU - Mauritius 5
NZ - Nuova Zelanda 5
RS - Serbia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
BY - Bielorussia 4
GY - Guiana 4
PA - Panama 4
SC - Seychelles 4
BH - Bahrain 3
BO - Bolivia 3
CR - Costa Rica 3
LV - Lettonia 3
SY - Repubblica araba siriana 3
A1 - Anonimo 2
BA - Bosnia-Erzegovina 2
EE - Estonia 2
KG - Kirghizistan 2
MN - Mongolia 2
NG - Nigeria 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CU - Cuba 1
Totale 58.881
Città #
Ann Arbor 19.992
Frankfurt am Main 5.145
Singapore 1.520
Ashburn 1.302
Woodbridge 1.151
Hong Kong 1.125
Wilmington 1.092
Chandler 942
Fairfield 884
Milan 792
Houston 614
Dublin 601
Jacksonville 504
Seattle 373
Beijing 338
Kraków 329
Santa Clara 317
Dearborn 310
Ho Chi Minh City 306
Cambridge 268
Hefei 268
Rome 260
New York 238
Princeton 232
Los Angeles 228
Dong Ket 220
Vienna 207
Hanoi 199
Nanjing 191
Shanghai 152
Dallas 151
Seoul 148
Boardman 145
Altamura 131
Guangzhou 130
Chicago 121
Jakarta 117
São Paulo 115
Toronto 115
Lawrence 107
Council Bluffs 101
Buffalo 94
The Dalles 92
Brussels 84
Lachine 80
San Diego 80
Moscow 77
Tokyo 71
Helsinki 69
Florence 58
Munich 58
Ottawa 49
Warsaw 47
Brooklyn 46
Orem 46
Fremont 44
Jinan 44
London 44
Amsterdam 43
Tianjin 43
Falls Church 42
Hangzhou 40
Montréal 39
Hebei 38
Montreal 38
Phoenix 38
Shenyang 38
Nanchang 37
Andover 36
Chennai 35
Nuremberg 35
Turin 35
Changsha 34
Denver 34
Hyderabad 34
Johannesburg 32
Rio de Janeiro 30
Huizen 29
Kent 29
San Jose 29
Brasília 28
Norwalk 28
Stockholm 28
Atlanta 27
Poplar 27
Salt Lake City 26
Zhengzhou 26
Brescia 25
Columbus 25
Jiaxing 25
Mountain View 25
Ha Long 23
Paris 23
Turku 23
Biên Hòa 22
Da Nang 22
Monza 22
Bologna 21
Boston 21
Can Tho 21
Totale 43.840
Nome #
Novel carboxylate-based glycolipids: TLR4 antagonism, MD-2 binding and self-assembly properties 770
Toll-like receptor 4 modulation influences human neural stem cell proliferation and differentiation 753
Structure–Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) Antagonists 738
Synthetic and natural small molecule TLR4 antagonists inhibit motoneuron death in cultures from ALS mouse model 721
Structural characterization of aerogels derived from enzymatically oxidized galactomannans of fenugreek, sesbania and guar gums 705
Selective cytotoxicity of a bicyclic Ras inhibitor in cancer cells expressing K-RasG13D 677
Recent advances on Toll-like receptor 4 modulation: new therapeutic perspectives 658
Amphiphilic Guanidinocalixarenes Inhibit Lipopolysaccharide (LPS)-and Lectin-Stimulated Toll-like Receptor 4 (TLR4) Signaling 656
First experimental identification of Ras-inhibitor binding interface using a water-soluble Ras ligand 640
Dye-sensitized photocatalytic hydrogen production: Distinct activity in a glucose derivative of a phenothiazine dye 633
TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection 628
Co-administration of Antimicrobial Peptides Enhances Toll-like Receptor 4 Antagonist Activity of a Synthetic Glycolipid 605
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors 602
The Multi-Level Mechanism of Action of a Pan-Ras Inhibitor Explains its Antiproliferative Activity on Cetuximab-Resistant Cancer Cells 596
Glucose-derived Ras pathway inhibitors: evidence of Ras-ligand binding and Ras-GEF (Cdc25) interaction inhibition 594
Functional characterization of E. coli LptC: Interaction with LPS and a synthetic ligand 588
A new advanced cellular model of functional cholinergic-like neurons developed by reprogramming the human SH-SY5Y neuroblastoma cell line 584
Dye-Sensitized Photocatalytic Hydrogen Generation: Efficiency Enhancement by Organic Photosensitizer-Coadsorbent Intermolecular Interaction 583
Binding properties and biological characterization of new sugar-derived Ras ligands 581
Modulation of CD14 and TLR4·MD-2 activities by a synthetic lipid A mimetic 581
The role of carbohydrates in the lipopolysaccharide (LPS)/toll-like receptor 4 (TLR4) Signalling 580
Structure and inflammatory activity of the LPS isolated from Acetobacter pasteurianus CIP103108 569
Synthesis of the New Cyanine-Labeled Bacterial Lipooligosaccharides for Intracellular Imaging and in Vitro Microscopy Studies 566
Metabolism of Phosphatidylinositol 4-Kinase IIIα-Dependent PI4P Is Subverted by HCV and Is Targeted by a 4-Anilino Quinazoline with Antiviral Activity 562
Exploring the LPS/TLR4 signal pathway with small molecules 559
Glycolipids and benzylammonium lipids as novel antisepsis agents: Synthesis and biological characterization 558
Trehalose- and glucose-derived glycoamphiphiles: Small-molecule and nanoparticle toll-like receptor 4 (TLR4) modulators 557
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors 555
Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice 554
Toll-like Receptor 4 (TLR4) Modulation by Synthetic and Natural Compounds: An Update 552
A Synthetic Lipid A Mimetic Modulates Human TLR4 Activity 548
Glycolipid-based TLR4 Modulators and Fluorescent Probes: Rational Design, Synthesis, and Biological Properties 548
Uniform lipopolysaccharide (LPS)-loaded magnetic nanoparticles for the investigation of LPS-TLR4 signaling 546
Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists 535
Effect of chemical modulation of toll-like receptor 4 in an animal model of ulcerative colitis 533
Synthesis and biological evaluation of novel lipid A antagonists 532
Synthetic molecules and functionalized nanoparticles targeting the LPS-TLR4 signaling: a new generation of immunotherapeutics 526
Hemin and a metabolic derivative coprohemin modulate the TLR4 pathway differently through different molecular targets 524
How do viruses interfere with Toll-like receptor 4? 522
The cationic amphiphile 3,4-bis (tetradecyloxy) benzylamine inhibits LPS signaling by competing with endotoxin for CD14 binding 521
A new isoluminol reagent for chemiluminescence labeling of proteins 511
The synthetic glycolipid-based TLR4 antagonist FP7 negatively regulates in vitro and in vivo haematopoietic and non-haematopoietic vascular TLR4 signalling 500
Inhibition of lipid A stimulated activation of human dendritic cells and macrophages by amino and hydroxylamino monosaccharides 498
TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis 498
Modulation of LPS signaling through TLR4 agonists and antagonists 496
Design, Synthesis and Biological Evaluation of Levoglucosenone-derived Ras Activation Inhibitors 492
Design and characterisation of a new class of inhibitors of Ras activation 491
Sugar-derived Ras inhibitors: Group epitope mapping by NMR spectroscopy and biological evaluation 490
Evidence of a specific interaction between new synthetic antisepsis agents and CD14 489
Compound for the covalent attachment of the chemiluminescent probe N-(4-Aminobutyl)-N-ethylisoluminol (ABEI) to target molecules and uses thereof 488
Clustered carbohydrates in synthetic vaccines 483
Rigid polycycles and peptidomimetics from carbohydrate synthons 482
Multivalent glycoconjugates as anti-pathogenic agents 482
Design, synthesis and biological evaluation of sugar-derived Ras inhibitors 476
Editorial 473
Optimizing operating conditions and electrochemical characterization of glucose-gluconate alkaline fuel cells 468
Carbohydrate-based bioactive compounds for medicinal chemistry applications 467
Glycoconjugates in cancer therapy 464
Arabinose-derived Bicyclic Amino Acids: Synthesis, Conformational Analysis and Construction of an avb3-selective RGD Peptide 462
Chemoselective neoglycosylation 457
Chemistry of lipid a: At the heart of innate immunity 456
NEW SYNTHETIC AGONISTS OF TLR4 RECEPTOR 455
Looking forward: A glance into the future of organic chemistry 450
Carbohydrate Scaffolds for the Production of Bioactive Compounds 445
Novel α-conotoxin from Conus spurius and the α-conotoxin EI share high-affinity potentiation and low-affinity inhibition of nicotinic acetylcoline receptors 443
Studies on the mechanism of action of a new class of inhibitors of Ras activation 442
Polycyclic Scaffolds from Fructose 439
Sugar-derived amino acids: powerful secondary structure inducing elements in the design of novel peptidomimetics 439
A novel small molecule TLR4 antagonist (IAXO-102) negatively regulates non-hematopoietic toll like receptor 4 signalling and inhibits aortic aneurysms development 438
Clicked and long spaced galactosyl- and lactosylcalix[4]arenes: New multivalent galectin-3 ligands 436
Glycoconjugate and oligosaccharide mimetics by chemoselective ligation 434
Synthesis and biological evaluation of an anticancer vaccine containing the C-glycoside analogue of the Tn epitope 432
Solution and solid-phase chemoselective synthesis of (1-6)-amino(methoxy) di- and trisaccharide analogues 431
Sugar-Based Inhibitors of Ras Activation: Biological Activity and Identification of Ras–Inhibitor Binding Interface 429
Chemoselective Ligation in Glycochemistry 428
Assembly of binding loops on aromatic templates as V CAM-1 mimetics 427
Extending chemoselective ligation to sugar chemistry:convergent assembly of bioactive neoglycoconjugates 425
Synthesis of imino-C-disaccharides related to sucrose 423
The Role of TLR4 in Neural Stem Cells–Mediated Neurogenesis and Neuroinflammation 423
Discrimination Properties of Tetraamidic Branched Selectors 422
Synthesis of imino sugar scaffolds for the generation of glycosidase inhibitor libraries 420
The EuroSciCon's 2015 Innate Immunity Summit 418
Carbohydrate-based Scaffolds for the generation of sortiments of bioactive compounds 416
A new procedure for the synthesis of C-glycosides of nojirimycin 415
Synthesis of bicyclic sugar azido acids and their incorporation in cyclic peptides 412
Conversion of lactose into mimics of N-acetyllactosamine 410
Stepwise synthesis and structural characterization of calix[4]- and calix[5]arenes bearing a functionalized arm on the methylene bridge 410
Stereoselective synthesis of α-C-glycosides of N-acetylgalactosamine 408
Chemoselective glycosylation techniques for the synthesis of bioactive neoglycoconjugates, glyconanoparticles and glycoarrays 407
D-glucose as a regioselectively addressable scaffold for combinatorial chemistry on solid phase 407
Molecular simplification of lipid A structure: TLR4-modulating cationic and anionic amphiphiles 407
Lipid A antagonists with anti-septic shock, anti-inflammatory, anti-ischemia and analgesic activity 402
Regioselection and orthogonality of the 1-phenyl-3-butenyl (PBU) protecting group in glucopyranosides 400
The bone morphogenic protein antagonist Drm/gremlin is a novel pro- angiogenic factor 399
Glycidic scaffolds in Peptidomimetic synthesis 395
Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants 395
Bicyclic carbohydrate-derived scaffolds for combinatorial libraries 394
Chemo- and stereoselective glycosylation of hydroxylamino derivatives: A versatile approach to glycoconjugates 387
Synthesis and conformational analysis of novel N(OCH3) disaccharide analogues 386
Tin-mediated regioselective acylation of unprotected sugars on solid phase 385
Totale 50.297
Categoria #
all - tutte 141.631
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 141.631


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216.248 0 0 0 0 0 0 1.033 1.187 911 1.052 816 1.249
2021/202211.080 1.142 1.083 967 1.112 887 869 785 847 676 868 787 1.057
2022/20238.296 1.376 1.724 1.100 997 928 1.111 161 295 250 175 104 75
2023/20242.842 84 188 345 160 351 433 448 141 184 86 110 312
2024/20256.194 324 548 455 326 461 300 334 353 588 926 547 1.032
2025/20268.089 1.885 981 1.133 1.638 1.611 788 53 0 0 0 0 0
Totale 60.269